355 related articles for article (PubMed ID: 33966039)
1. TRIM25 regulates oxaliplatin resistance in colorectal cancer by promoting EZH2 stability.
Zhou S; Peng J; Xiao L; Zhou C; Fang Y; Ou Q; Qin J; Liu M; Pan Z; Hou Z
Cell Death Dis; 2021 May; 12(5):463. PubMed ID: 33966039
[TBL] [Abstract][Full Text] [Related]
2. A KLF4/PiHL/EZH2/HMGA2 regulatory axis and its function in promoting oxaliplatin-resistance of colorectal cancer.
Deng X; Kong F; Li S; Jiang H; Dong L; Xu X; Zhang X; Yuan H; Xu Y; Chu Y; Peng H; Guan M
Cell Death Dis; 2021 May; 12(5):485. PubMed ID: 33986248
[TBL] [Abstract][Full Text] [Related]
3. Suppression MGP inhibits tumor proliferation and reverses oxaliplatin resistance in colorectal cancer.
Huang C; Wang M; Wang J; Wu D; Gao Y; Huang K; Yao X
Biochem Pharmacol; 2021 Jul; 189():114390. PubMed ID: 33359068
[TBL] [Abstract][Full Text] [Related]
4. Identification of TRIM25 as a Negative Regulator of Caspase-2 Expression Reveals a Novel Target for Sensitizing Colon Carcinoma Cells to Intrinsic Apoptosis.
Nasrullah U; Haeussler K; Biyanee A; Wittig I; Pfeilschifter J; Eberhardt W
Cells; 2019 Dec; 8(12):. PubMed ID: 31842382
[TBL] [Abstract][Full Text] [Related]
5. TRIM25 is associated with cisplatin resistance in non-small-cell lung carcinoma A549 cell line via downregulation of 14-3-3σ.
Qin X; Qiu F; Zou Z
Biochem Biophys Res Commun; 2017 Nov; 493(1):568-572. PubMed ID: 28867193
[TBL] [Abstract][Full Text] [Related]
6. Role of Dicer in regulating oxaliplatin resistance of colon cancer cells.
Lai HH; Lin LJ; Hung LY; Chen PS
Biochem Biophys Res Commun; 2018 Nov; 506(1):87-93. PubMed ID: 30336979
[TBL] [Abstract][Full Text] [Related]
7. LncRNA CACS15 contributes to oxaliplatin resistance in colorectal cancer by positively regulating ABCC1 through sponging miR-145.
Gao R; Fang C; Xu J; Tan H; Li P; Ma L
Arch Biochem Biophys; 2019 Mar; 663():183-191. PubMed ID: 30639170
[TBL] [Abstract][Full Text] [Related]
8. Kruppel-like factor 5 enhances proliferation, lipid droplet formation and oxaliplatin resistance in colorectal cancer by promoting fatty acid binding protein 6 transcription.
Zuo Q; Xu Q; Li Z; Luo D; Peng H; Duan Z
Anticancer Drugs; 2023 Nov; 34(10):1171-1182. PubMed ID: 37067981
[TBL] [Abstract][Full Text] [Related]
9. JP3, an antiangiogenic peptide, inhibits growth and metastasis of gastric cancer through TRIM25/SP1/MMP2 axis.
Chen JJ; Ren YL; Shu CJ; Zhang Y; Chen MJ; Xu J; Li J; Li AP; Chen DY; He JD; Shu YQ; Zhou JW
J Exp Clin Cancer Res; 2020 Jun; 39(1):118. PubMed ID: 32576271
[TBL] [Abstract][Full Text] [Related]
10. ATAD2 drives colorectal cancer progression by regulating TRIM25 expression via a positive feedback loop with E2F transcriptional factors.
Tong Y; Li J; Peng M; Qian Q; Shi W; Chen Z; Liu B
Biochem Biophys Res Commun; 2022 Feb; 594():146-152. PubMed ID: 35085891
[TBL] [Abstract][Full Text] [Related]
11. The E3 Ligase TRIM25 Impairs Apoptotic Cell Death in Colon Carcinoma Cells via Destabilization of Caspase-7 mRNA: A Possible Role of hnRNPH1.
Nasrullah U; Stanke K; Recknagel V; Bozkurt S; Wurzel P; Gauer S; Imre G; Münch C; Pfeilschifter J; Eberhardt W
Cells; 2023 Jan; 12(1):. PubMed ID: 36611995
[TBL] [Abstract][Full Text] [Related]
12. The ubiquitin ligase TRIM25 targets ERG for degradation in prostate cancer.
Wang S; Kollipara RK; Humphries CG; Ma SH; Hutchinson R; Li R; Siddiqui J; Tomlins SA; Raj GV; Kittler R
Oncotarget; 2016 Oct; 7(40):64921-64931. PubMed ID: 27626314
[TBL] [Abstract][Full Text] [Related]
13. Prostaglandin F
Wang YJ; Xie XL; Liu HQ; Tian H; Jiang XY; Zhang JN; Chen SX; Liu T; Wang SL; Zhou X; Jin XX; Liu SM; Jiang HQ
World J Gastroenterol; 2023 Oct; 29(39):5452-5470. PubMed ID: 37900995
[TBL] [Abstract][Full Text] [Related]
14. The ubiquitin ligase TRIM25 inhibits hepatocellular carcinoma progression by targeting metastasis associated 1 protein.
Zang HL; Ren SN; Cao H; Tian XF
IUBMB Life; 2017 Oct; 69(10):795-801. PubMed ID: 28861931
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNAs: Key regulators in oxaliplatin resistance of colorectal cancer.
Qi FF; Yang Y; Zhang H; Chen H
Biomed Pharmacother; 2020 Aug; 128():110329. PubMed ID: 32502843
[TBL] [Abstract][Full Text] [Related]
16. The c-Myc/miR-27b-3p/ATG10 regulatory axis regulates chemoresistance in colorectal cancer.
Sun W; Li J; Zhou L; Han J; Liu R; Zhang H; Ning T; Gao Z; Liu B; Chen X; Ba Y
Theranostics; 2020; 10(5):1981-1996. PubMed ID: 32104496
[TBL] [Abstract][Full Text] [Related]
17. TRIM25 enhances cell growth and cell survival by modulating p53 signals via interaction with G3BP2 in prostate cancer.
Takayama KI; Suzuki T; Tanaka T; Fujimura T; Takahashi S; Urano T; Ikeda K; Inoue S
Oncogene; 2018 Apr; 37(16):2165-2180. PubMed ID: 29379164
[TBL] [Abstract][Full Text] [Related]
18. RIG-I regulates myeloid differentiation by promoting TRIM25-mediated ISGylation.
Wu SF; Xia L; Shi XD; Dai YJ; Zhang WN; Zhao JM; Zhang W; Weng XQ; Lu J; Le HY; Tao SC; Zhu J; Chen Z; Wang YY; Chen S
Proc Natl Acad Sci U S A; 2020 Jun; 117(25):14395-14404. PubMed ID: 32513696
[TBL] [Abstract][Full Text] [Related]
19. Tripartite motif containing 25 promotes proliferation and invasion of colorectal cancer cells through TGF-β signaling.
Sun N; Xue Y; Dai T; Li X; Zheng N
Biosci Rep; 2017 Aug; 37(4):. PubMed ID: 28620119
[TBL] [Abstract][Full Text] [Related]
20. The E3 ubiquitin ligase TRIM25 regulates adipocyte differentiation via proteasome-mediated degradation of PPARγ.
Lee JM; Choi SS; Lee YH; Khim KW; Yoon S; Kim BG; Nam D; Suh PG; Myung K; Choi JH
Exp Mol Med; 2018 Oct; 50(10):1-11. PubMed ID: 30323259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
